ArticleThe Journal of physiology2008

Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.

Carley R Benton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.